Skip to main
DCGO

DocGo (DCGO) Stock Forecast & Price Target

DocGo (DCGO) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

DocGo Inc. reported an EBITDA of $830,000 with a 20% margin, indicating substantial profitability improvements as the company benefits from economies of scale. Patient volume growth was robust across various services, including an 11% increase in medical transportation trips and a remarkable 113% surge in home visits year-over-year, which contributed to an optimistic revision of revenue and adjusted EBITDA guidance for 2026. Additionally, with improvements in operational efficiency and strong demand management in the core transportation business, the company anticipates further enhancements in gross profit margins and continued revenue growth driven by strategic initiatives in both its Mobile Health Services and Transportation Services segments.

Bears say

DocGo Inc. has reported a concerning decline in mobile revenue for the fourth quarter of 2025, with a drop of 3% year-over-year and 8% quarter-over-quarter when excluding acquisitions and specific immigration work. The company faces challenges in achieving its adjusted EBITDA guidance, as non-GAAP operating expenses would need to decrease significantly to align with projected revenue growth, which has been hindered by a decline in organic non-migrant Mobile Health revenue despite a reported 47% growth that includes contributions from new acquisitions. Furthermore, ongoing elevated costs related to migrant revenue, along with difficulties in scaling the business, suggest lingering operational issues and a challenging revenue outlook for the core Mobile Health services segment.

DocGo (DCGO) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of DocGo and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About DocGo (DCGO) Forecast

Analysts have given DocGo (DCGO) a Buy based on their latest research and market trends.

According to 4 analysts, DocGo (DCGO) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

DocGo (DCGO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.